DE60330233D1 - Arsentherapie zur behandlung von autoimmunerkrankungen - Google Patents

Arsentherapie zur behandlung von autoimmunerkrankungen

Info

Publication number
DE60330233D1
DE60330233D1 DE60330233T DE60330233T DE60330233D1 DE 60330233 D1 DE60330233 D1 DE 60330233D1 DE 60330233 T DE60330233 T DE 60330233T DE 60330233 T DE60330233 T DE 60330233T DE 60330233 D1 DE60330233 D1 DE 60330233D1
Authority
DE
Germany
Prior art keywords
autoimmune diseases
arsentherapy
treatment
medicament
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60330233T
Other languages
English (en)
Inventor
Alix Kmar Chelbi
Pedro Bobe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Application granted granted Critical
Publication of DE60330233D1 publication Critical patent/DE60330233D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60330233T 2002-04-26 2003-04-25 Arsentherapie zur behandlung von autoimmunerkrankungen Expired - Lifetime DE60330233D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0205276A FR2838965B1 (fr) 2002-04-26 2002-04-26 Therapie par l'arsenic du syndrome autoimmunlymphoproliferatif de type apls chez la souris comme chez l'homme
PCT/FR2003/001314 WO2003090766A1 (fr) 2002-04-26 2003-04-25 Therapie par l'arsenic du styndrome autoimmunlymphoproliferatif de type apls chez la souris comme chez l'homme

Publications (1)

Publication Number Publication Date
DE60330233D1 true DE60330233D1 (de) 2010-01-07

Family

ID=28799974

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60330233T Expired - Lifetime DE60330233D1 (de) 2002-04-26 2003-04-25 Arsentherapie zur behandlung von autoimmunerkrankungen

Country Status (9)

Country Link
US (2) US20050163863A1 (de)
EP (1) EP1499330B1 (de)
AT (1) ATE449607T1 (de)
AU (1) AU2003262832A1 (de)
CA (1) CA2483764C (de)
DE (1) DE60330233D1 (de)
ES (1) ES2337568T3 (de)
FR (1) FR2838965B1 (de)
WO (1) WO2003090766A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8394422B2 (en) * 2002-04-26 2013-03-12 Centre National De La Recherche Scientifique (Cnrs) Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans
US20060292243A1 (en) * 2005-06-24 2006-12-28 Shao-Chi Hsin Arsenic compounds for the treatment of the arsenic-sensitive blast-cell related diseases
US8945505B2 (en) * 2007-02-02 2015-02-03 Panaphix, Inc. Use of arsenic compounds for treatment of pain and inflammation
FR3004949B1 (fr) * 2013-04-26 2016-02-05 Centre Nat Rech Scient Traitement de maladies autoimmunes et inflammatoires par les composes de l'arsenic as203 et/ou as205 administres par voie locale
US10716807B2 (en) * 2017-05-09 2020-07-21 Medsenic Method of treating relapsing-remitting multiple sclerosis using arsenic trioxide

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2539993A1 (fr) 1983-01-28 1984-08-03 Darcheux Mario Baume agissant sur les plaies cancereuses
FR2572730B1 (fr) 1984-11-02 1987-12-11 Centre Nat Rech Scient Nouveaux derives de l'arsenic, leur preparation et leur application, notamment comme medicaments antiparasitaires
IT1280014B1 (it) 1993-03-17 1997-12-23 Walter Tarello Farmaci attivi contro l'agente eziologico della sindrome da astenia cronica
ITTO930510A1 (it) 1993-07-09 1993-10-07 Walter Tarello Farmaci attivi contro la chronic fatigue syndrome (c.f.s.)
EP0804928B1 (de) * 1994-02-18 2004-10-20 Tamara Vasilievna Vorobieva Substanz mit immunonodulierender wirkung und zur verringerung der disfunktion des gewebezellenregelungssystems
US5550153A (en) 1994-11-14 1996-08-27 Kerz; Phillip D. Method for treating heartworm-infected canines
CN1175451A (zh) * 1997-07-20 1998-03-11 迟经惠 红斑狼疮膏
EP1119365A4 (de) 1997-07-24 2003-08-13 Univ Jefferson Zusammensetzung und methode zur verwendung von tumorzellen
JP2001519366A (ja) 1997-10-15 2001-10-23 ポーラクス バイオファーマシュティカルズ，インコーポレーテッド ヒ素化合物を用いた、原発性および転移性の腫瘍性疾患を治療するための組成物および方法
US6770304B2 (en) 1997-11-10 2004-08-03 Memorial Sloan-Kettering Cancer Center Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
CN1233476A (zh) 1998-04-24 1999-11-03 陆道培 治疗急性白血病的药物及其制备方法
KR100272835B1 (ko) 1998-05-08 2000-11-15 배일주 천연 화학물질 육산화사비소의 신규한 항종양 치료제로서의 용도 및 그 약학적 조성물
FR2781674B1 (fr) * 1998-07-31 2002-06-28 Inst Nat Sante Rech Med Utilisation de nouveaux agents inducteurs de mort cellulaire en synergie avec les interferons
FR2782010A1 (fr) 1998-08-06 2000-02-11 Inst Vaisseaux Et Du Sang Nouvelle utilisation d'un compose d'arsenic vis-a-vis de la leucemie megacaryocytaire ou plaquettaire
US6191123B1 (en) 1999-03-19 2001-02-20 Parker Hughes Institute Organic-arsenic compounds
TW200408407A (en) * 2001-11-30 2004-06-01 Dana Farber Cancer Inst Inc Methods and compositions for modulating the immune system and uses thereof
US8394422B2 (en) * 2002-04-26 2013-03-12 Centre National De La Recherche Scientifique (Cnrs) Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans

Also Published As

Publication number Publication date
EP1499330A1 (de) 2005-01-26
CA2483764A1 (fr) 2003-11-06
AU2003262832A1 (en) 2003-11-10
ATE449607T1 (de) 2009-12-15
US20090098216A1 (en) 2009-04-16
US8497300B2 (en) 2013-07-30
EP1499330B1 (de) 2009-11-25
ES2337568T3 (es) 2010-04-27
FR2838965B1 (fr) 2004-06-25
US20050163863A1 (en) 2005-07-28
CA2483764C (fr) 2011-03-08
WO2003090766A1 (fr) 2003-11-06
FR2838965A1 (fr) 2003-10-31

Similar Documents

Publication Publication Date Title
EA200201247A1 (ru) Соединения для лечения болезни альцгеймера
DE60124085D1 (de) Pde-v hemmer zur behandlung von morbus parkinson
DE60236413D1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
ATE389395T1 (de) Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson
EA200601212A1 (ru) Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение
ATE254461T1 (de) Behandlung von augenschmerzen
ATE412646T1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
ATE390928T1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
DE60139466D1 (de) Behandlung von diabetes
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
ATE443704T1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
DE60220385D1 (de) Benzimidazole zur behandlung sexueller fehlfunktionen
ATE357912T1 (de) Intrakorporelle medikamente zur hoch- energetischen phototherapeutischen behandlung von krankheiten
DE69924146D1 (de) Etherlysophospholipide zur behandlung von chronischen entzündlichen erkrankungen
DE60330233D1 (de) Arsentherapie zur behandlung von autoimmunerkrankungen
ATE432936T1 (de) Imidazotriazin verbindungen zur behandlung von krebserkrankungen
ATE346597T1 (de) Carbamate verbindungen zur behandlung oder verhutung von psychotischen krankheiten
ATE542542T1 (de) Verwendung von gp130 aktivatoren zur behandlung von diabetischer neuropathie
ATE453386T1 (de) Polyamin-verbindungen zur behandlung von chemokin-rezeptor-vermittelten krankheiten
SE0004827D0 (sv) Therapeutic compounds
EA200600115A1 (ru) Производные 2-аминобензойной кислоты
ATE302009T1 (de) Ubichinon qn zur behandlung von migräneschmerzen
EA200600989A1 (ru) Применение габоксадола для лечения бессонницы

Legal Events

Date Code Title Description
8364 No opposition during term of opposition